Disruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase "Asian" variant.
paper
Cited
Public
Unavailable
- Authors
- Larson, Heather N; Weiner, Henry; Hurley, Thomas D
- Year
- 2005
- Journal
- The Journal of biological chemistry
- PMID
- 15983043
- DOI
- 10.1074/jbc.M502345200
- PMCID
- PMC1262676
Mitochondrial aldehyde dehydrogenase (ALDH2) is the major enzyme that oxidizes ethanol-derived acetaldehyde. A nearly inactive form of the enzyme, ALDH2*2, is found in about 40% of the East Asian population. This variant enzyme is defined by a glutamate to lysine substitution at residue 487 located within the oligomerization domain. ALDH2*2 has an increased Km for its coenzyme, NAD+, and a decreased kcat, which lead to low activity in vivo. Here we report the 2.1 A crystal structure of ALDH2*2. The structure shows a large disordered region located at the dimer interface that includes much of the coenzyme binding cleft and a loop of residues that form the base of the active site. As a consequence of these structural changes, the variant enzyme exhibits rigid body rotations of its catalytic and coenzyme-binding domains relative to the oligomerization domain. These structural perturbations are the direct result of the inability of lysine 487 to form important stabilizing hydrogen bonds with arginines 264 and 475. Thus, the elevated Km for coenzyme exhibited by this variant probably reflects the energetic penalty for reestablishing this site for productive coenzyme binding, whereas the structural alterations near the active site are consistent with the lowered Vmax.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genetics and alcoholism. | 2013 | 23712313 |
| Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant. | 2009 | 19456322 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| ALDH2/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury. | Chen X et al. | β | 2026 | β |
| Emerging importance of ALDH2 in liver diseases and its potential therapeutic role. | Wang S et al. | β | 2026 | β |
| ALDH2 Deficiency and Alcohol Intake in the United States: Opportunity for Precision Cancer Prevention. | Forman D et al. | β | 2025 | β |
| ALDH2 in autophagy and cell death: molecular mechanisms and implications for diseases. | Duan Y et al. | β | 2025 | β |
| Design, Synthesis, and Study of Protective Activity Against Stroke for Novel Water-Soluble Aldehyde Dehydrogenase 2 Activators. | Zhao F et al. | β | 2025 | β |
| From aldehyde metabolism to delay aging: targeting ALDH2 as a novel strategy. | Yang P et al. | β | 2025 | β |
| High-level soluble expression of human aldehyde dehydrogenase 2 in Escherichia coli achieved through lactose-mediated induction optimization. | Li H et al. | β | 2025 | β |
| Targeting ALDH2 to promote skeletal muscle health: A novel strategy against mitochondrial dysfunction. | Andrade KSG et al. | β | 2025 | β |
| Advances in Factors Affecting ALDH2 Activity and its Mechanisms. | Liu Y et al. | β | 2024 | β |
| Endogenous ethanol production in health and disease. | Meijnikman AS et al. | β | 2024 | β |
| Genetic architecture of alcohol consumption identified by a genotype-stratified GWAS and impact on esophageal cancer risk in Japanese people. | Koyanagi YN et al. | β | 2024 | β |
| Research Progress on the Correlation between Acetaldehyde Dehydrogenase 2 and Hepatocellular Carcinoma Development. | Yang D et al. | β | 2024 | β |
| The biochemistry of the carcinogenic alcohol metabolite acetaldehyde. | Thomas LA et al. | β | 2024 | β |
| Uncovering newly identified aldehyde dehydrogenase 2 genetic variants that lead to acetaldehyde accumulation after an alcohol challenge. | Rwere F et al. | β | 2024 | β |
| Emerging functions of pseudoenzymes. | Goldberg T et al. | β | 2023 | β |
| p53 protects against alcoholic fatty liver disease via ALDH2 inhibition. | Yao P et al. | β | 2023 | β |
| SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common <i>ALDH2</i> alcohol flushing variant. | Guo H et al. | β | 2023 | β |
| The role of acetaldehyde dehydrogenase 2 in the pathogenesis of liver diseases. | Wu YC et al. | β | 2023 | β |
| The role of aldehyde dehydrogenase 2 in cardiovascular disease. | Zhang J et al. | β | 2023 | β |
| The Stage-Based Model of Addiction-Using <i>Drosophila</i> to Investigate Alcohol and Psychostimulant Responses. | Cummins-Beebee PN et al. | β | 2023 | β |
| Aldehyde dehydrogenase 2 and arrhythmogenesis. | Jin J et al. | β | 2022 | β |
| Can gene therapy be used to prevent cancer? Gene therapy for aldehyde dehydrogenase 2 deficiency. | Montel RA et al. | β | 2022 | β |
| Computational Investigation of Structural Basis for Enhanced Binding of Isoflavone Analogues with Mitochondrial Aldehyde Dehydrogenase. | Zhang Y et al. | β | 2022 | β |
| Diverse Molecular Mechanisms Underlying Pathogenic Protein Mutations: Beyond the Loss-of-Function Paradigm. | Backwell L et al. | β | 2022 | β |
| Genetic Variations of ALDH (rs671) Are Associated With the Persistence of HBV Infection Among the Chinese Han Population. | Shang D et al. | β | 2022 | β |
| Structural and biochemical evidence that ATP inhibits the cancer biomarker human aldehyde dehydrogenase 1A3. | CastellvΓ A et al. | β | 2022 | β |
| Virtual Screening of FDA-Approved Drugs for Enhanced Binding with Mitochondrial Aldehyde Dehydrogenase. | Zhou B et al. | β | 2022 | β |
| Annotation of 1350 Common Genetic Variants of the 19 ALDH Multigene Family from Global Human Genome Aggregation Database (gnomAD). | Chen CH et al. | β | 2021 | β |
| A systems omics-based approach to decode substance use disorders and neuroadaptations. | Veerappa A et al. | β | 2021 | β |
| Insights into Aldehyde Dehydrogenase Enzymes: A Structural Perspective. | Shortall K et al. | β | 2021 | β |
| The discovery of novel small molecule allosteric activators of aldehyde dehydrogenase 2. | Tian W et al. | β | 2021 | β |
| The Effect of Ethanol Consumption on Composition and Morphology of Femur Cortical Bone in Wild-Type and ALDH2*2-Homozygous Mice. | Malkovskiy AV et al. | β | 2021 | β |
| Aldehyde Dehydrogenase 2 Ameliorates Chronic Alcohol Consumption-Induced Atrial Fibrillation through Detoxification of 4-HNE. | Hsu LA et al. | β | 2020 | β |
| Aldehyde Dehydrogenase, Liver Disease and Cancer. | Wang W et al. | β | 2020 | β |
| Association of alcohol dehydrogenase and aldehyde dehydrogenase Polymorphism with Spontaneous Deep Intracerebral Haemorrhage in the Taiwan population. | Huang YH et al. | β | 2020 | β |
| Design, synthesis and the structure-activity relationship of agonists targeting on the ALDH2 catalytic tunnel. | Cheng MC et al. | β | 2020 | β |
| Digenic mutations in <i>ALDH2</i> and <i>ADH5</i> impair formaldehyde clearance and cause a multisystem disorder, AMeD syndrome. | Oka Y et al. | β | 2020 | β |
| E487K-Induced Disorder in Functionally Relevant Dynamics of Mitochondrial Aldehyde Dehydrogenase 2. | Matsumoto S et al. | β | 2020 | β |
| Inhibition, crystal structures, and in-solution oligomeric structure of aldehyde dehydrogenase 9A1. | Wyatt JW et al. | β | 2020 | β |
| Protective effects of Alda-1, an ALDH2 activator, on alcohol-derived DNA damage in the esophagus of human ALDH2*2 (Glu504Lys) knock-in mice. | Hirohashi K et al. | β | 2020 | β |
| Revisiting pharmacology of oxidative stress and endothelial dysfunction in cardiovascular disease: Evidence for redox-based therapies. | Daiber A et al. | β | 2020 | β |
| Appropriate dose of ethanol exerts anti-senescence and anti-atherosclerosis protective effects by activating ALDH2. | Xue L et al. | β | 2019 | β |
| Emerging concepts in pseudoenzyme classification, evolution, and signaling. | Ribeiro AJM et al. | β | 2019 | β |
| Role of Alcohol Oxidative Metabolism in Its Cardiovascular and Autonomic Effects. | El-Mas MM et al. | β | 2019 | β |
| Role of Aldehyde Dehydrogenases in Physiopathological Processes. | RodrΓguez-Zavala JS et al. | β | 2019 | β |
| Alcohol Metabolic Inefficiency: Structural Characterization of Polymorphism-Induced ALDH2 Dysfunctionality and Allosteric Site Identification for Design of Potential Wildtype Reactivators. | Adeniji EA et al. | β | 2018 | β |
| Aldehyde dehydrogenase 2 activation and coevolution of its Ξ΅PKC-mediated phosphorylation sites. | Nene A et al. | β | 2017 | β |
| Bio-Zombie: the rise of pseudoenzymes in biology. | Murphy JM et al. | β | 2017 | β |
| Engineering an aldehyde dehydrogenase toward its substrates, 3-hydroxypropanal and NAD<sup>+</sup>, for enhancing the production of 3-hydroxypropionic acid. | Park YS et al. | β | 2017 | β |
| Human Second Window Pre-Conditioning and Post-Conditioning by Nitrite Is Influenced by a Common Polymorphism in Mitochondrial Aldehyde Dehydrogenase. | Ormerod JO et al. | β | 2017 | β |
| Live and let die: insights into pseudoenzyme mechanisms from structure. | Murphy JM et al. | β | 2017 | β |
| Susceptibility loci for metabolic syndrome and metabolic components identified in Han Chinese: a multi-stage genome-wide association study. | Zhu Y et al. | β | 2017 | β |
| Aldehyde dehydrogenase 2 inhibits inflammatory response and regulates atherosclerotic plaque. | Pan C et al. | β | 2016 | β |
| Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease. | GrΓΌnblatt E et al. | β | 2016 | β |
| Human-induced pluripotent stem cell approaches to model inborn and acquired metabolic heart diseases. | Chanana AM et al. | β | 2016 | β |
| Characterization of polymorphisms of genes ADH2, ADH3, ALDH2 and CYP2E1 and relationship to the alcoholism in a Colombian population. | MΓ©ndez C et al. | β | 2015 | β |
| Dead enzymes in the aldehyde dehydrogenase gene family: role in drug metabolism and toxicology. | Jackson BC et al. | β | 2015 | β |
| Glu504Lys Single Nucleotide Polymorphism of Aldehyde Dehydrogenase 2 Gene and the Risk of Human Diseases. | Zhao Y et al. | β | 2015 | β |
| Human ALDH1B1 polymorphisms may affect the metabolism of acetaldehyde and all-trans retinaldehyde--in vitro studies and computational modeling. | Jackson BC et al. | β | 2015 | β |
| Structural and functional analysis of betaine aldehyde dehydrogenase from Staphylococcus aureus. | Halavaty AS et al. | β | 2015 | β |
| Three missense variants of metabolic syndrome-related genes are associated with alpha-1 antitrypsin levels. | Setoh K et al. | β | 2015 | β |
| Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system. | Ebert AD et al. | β | 2014 | β |
| Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. | Chen CH et al. | β | 2014 | β |
| Why does the bone marrow fail in Fanconi anemia? | Garaycoechea JI et al. | β | 2014 | β |
| Catalytic contribution of threonine 244 in human ALDH2. | GonzΓ‘lez-Segura L et al. | β | 2013 | β |
| Genetics and alcoholism. | Edenberg HJ et al. | β | 2013 | β |
| Mitochondrial aldehyde dehydrogenase 2 activation and cardioprotection. | Gong D et al. | β | 2013 | β |
| New insights into the half-of-the-sites reactivity of human aldehyde dehydrogenase 1A1. | Yoval-SΓ‘nchez B et al. | β | 2013 | β |
| Structural determinants of oligomerization of Ξ΄(1)-pyrroline-5-carboxylate dehydrogenase: identification of a hexamerization hot spot. | Luo M et al. | β | 2013 | β |
| Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. | Koppaka V et al. | β | 2012 | β |
| Nitroglycerin use in myocardial infarction patients. | Ferreira JC et al. | β | 2012 | β |
| Vascular bioactivation of nitroglycerin by aldehyde dehydrogenase-2: reaction intermediates revealed by crystallography and mass spectrometry. | Lang BS et al. | β | 2012 | β |
| Conserved catalytic residues of the ALDH1L1 aldehyde dehydrogenase domain control binding and discharging of the coenzyme. | Tsybovsky Y et al. | β | 2011 | β |
| Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant. | Perez-Miller S et al. | β | 2010 | β |
| Aldehyde dehydrogenase 1B1: molecular cloning and characterization of a novel mitochondrial acetaldehyde-metabolizing enzyme. | Stagos D et al. | β | 2010 | β |
| Characterization of the East Asian variant of aldehyde dehydrogenase-2: bioactivation of nitroglycerin and effects of Alda-1. | Beretta M et al. | β | 2010 | β |
| Focus on: The cardiovascular system: what did we learn from the French (Paradox)? | Mochly-Rosen D et al. | β | 2010 | β |
| Inhibition of hepatic mitochondrial aldehyde dehydrogenase by carbon tetrachloride through JNK-mediated phosphorylation. | Moon KH et al. | β | 2010 | β |
| Mitochondrial aldehyde dehydrogenase and cardiac diseases. | Chen CH et al. | β | 2010 | β |
| Efficient expression of codon-adapted human acetaldehyde dehydrogenase 2 cDNA with 6xHis tag in Pichia pastoris. | Zhao Y et al. | β | 2009 | β |
| Redox-switch modulation of human SSADH by dynamic catalytic loop. | Kim YG et al. | β | 2009 | β |
| Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant. | Li H et al. | β | 2009 | β |
| The crystal structure of a ternary complex of betaine aldehyde dehydrogenase from Pseudomonas aeruginosa Provides new insight into the reaction mechanism and shows a novel binding mode of the 2'-phosphate of NADP+ and a novel cation binding site. | GonzΓ‘lez-Segura L et al. | β | 2009 | β |
| Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. | Chen CH et al. | β | 2008 | β |
| Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase. | Lowe ED et al. | β | 2008 | β |
| Enantioselective oxidation of trans-4-hydroxy-2-nonenal is aldehyde dehydrogenase isozyme and Mg2+ dependent. | Brichac J et al. | β | 2007 | β |
| Pharmacokinetic and pharmacodynamic basis for partial protection against alcoholism in Asians, heterozygous for the variant ALDH2*2 gene allele. | Peng GS et al. | β | 2007 | β |
| Structural and functional consequences of coenzyme binding to the inactive asian variant of mitochondrial aldehyde dehydrogenase: roles of residues 475 and 487. | Larson HN et al. | β | 2007 | β |
| Bioactivation of nitroglycerin by the mitochondrial aldehyde dehydrogenase. | Chen Z et al. | β | 2006 | β |
| Characterization of E. coli tetrameric aldehyde dehydrogenases with atypical properties compared to other aldehyde dehydrogenases. | RodrΓguez-Zavala JS et al. | β | 2006 | β |
| Molecular cloning and expression of a second zebrafish aldehyde dehydrogenase 2 gene (aldh2b). | Song W et al. | β | 2006 | β |